The use of multi-level modelling to produce virtual placebo groups for long-term assesment of MS drug effectiveness: experience from the risk sharing scheme

Fourth lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Chair: Prof Dr William Carroll.

Now Playing: The use of multi-level modelling to produce virtual placebo groups for long-term assesment of MS drug effectiveness: experience from the risk sharing scheme

Michael Lawton - Nov 15, 2018

Other recordings

Comi_G_2018_David plas 155341

Opening XXVI th Annual Meeting of The European Charcot Foundation by Giancarlo Comi

Opening 26th Annual Meeting of The European Charcot Foundation.

Trojano_M_2018_David plas 155671

XXVI Annual Meeting Opening Lecture

The role of long-term clinical studies in defining DMTs' profile

Sormani_M P_2018_David plas 156321

Statistical Problems

First lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Kappos_L_2018_David plas 156591

Methodology of extension studies

Second lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Peeters_L_2018_David plas 156921

Big data handling

Third lecture of Session I - Values and limits of long term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Cree_B A_2018_David plas 158111

The UCSF experience

First lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Dalla Costa_G_2018_David plas 158341

Clinically isolated syndrome

Second lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Iaffaldino_P_2018_David plas 158621

The Italian MS Registry

Third lecture of session II - Long-lasting post-marketing studies in Relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Rojas_J I_2018_David plas 159091

RelevarEM: the first MS national registry in Argentina and LATAM

Fourth lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.

Lorscheider_J_2018_David plas 164111

Secondary Progressive MS

First lecture of Session III - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.

Signori_A_2018_David plas 164461

Primary Progressive MS

Second lecture of Session III - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.

Hillert_J_2018_David plas 165171

The experience of the Swedish National Registry

Fourth lecture of session IV - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.

Hartung_H P _2018_David plas 167341

Interferons and GA

First lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.

Sorensen_P S_2018_David plas 167391

Oral treatments

Second lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.

Montalban_X_2018_David plas 167621

Antibody treatments

Third lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.

Kubala Havrdova_E_2018_David plas 167881

Natalizumab and BMT

Fourth lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.

Palace_J_2018_David plas 168721

Anti-MOG

First lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.

Fujihara_K_2018_David plas 168831

NMO Spectrum disorders

Second lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.

Ghezzi_A_2018_David plas 169231

Pediatric MS

Third lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.

Magyari_M_2018_David plas 169391

Nationwide real world experience with pediatric onset MS

Fourth lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.

Khella_S_L_2018_David plas 170811

Methodological aspects

First lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.

Freedman_M_2018_David plas 171341

DMTs and infections

Second lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.

Boyko_A_2018_David plas 171801

DMTs and risk of cancer

Third lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.

Vukusic_S_2018_David plas 172101

DMTs and reproduction

Fourth lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.

Schippling_S_2018_David plas 174761

OCT

First lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Leocani_L_2018_David plas 175191

EPS

Second lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Fazekas_F_2018_David plas 175431

Brain MRI

Third lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Tsagkas_C_2018_David plas 175561

Spinal cord MRI

Fourth lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Vermersch_P_2018_David plas 177451

Patient reported outcomes

First lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Langdon_D_2018_David plas 177771

Long-term studies of cognitive dysfunctions in MS

Second lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Uitdehaag_B_2018_David plas 178061

Fatigue

Third lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.

Feinstein_A_2018_David plas 178181

Depression

Fourth lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.